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A R T I C L E   I N F O A B S T R A C T 
Co-processing is currently of interest in the generation of high-functionality 
excipients for tablet formulation. In the present study, comparative analysis of the 
powder and tableting properties of three co-processed starches prepared by three 
different methods was carried out. The co-processed excipients consisting of maize 
starch (90%), acacia gum (7.5%) and colloidal silicon dioxide (2.5%) were prepared 
by co-dispersion (SAS-CD), co-fusion (SAS-CF) and co-granulation (SAS-CG). 
Powder properties of each co-processed excipient were characterized by measuring 
particle size, flow indices, particle density, dilution potential and lubricant 
sensitivity ratio. Heckel and Walker models were used to evaluate the compaction 
behaviour of the three co-processed starches. Tablets were produced with 
paracetamol as the model drug by direct compression on an eccentric Tablet Press 
fitted with 12 mm flat-faced punches and compressed at 216 MPa. The tablets were 
stored at room temperature for 24 h prior to evaluation. The results revealed that co-
granulated co-processed excipient (SAS-CG) gave relatively better properties in 
terms of flow, compressibility, dilution potential, deformation, disintegration, 
crushing strength and friability. This study has shown that the method of co-
processing influences the powder and tableting properties of the co-processed 
excipient. 
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INTRODUCTION 
It has been estimated that solid dosage forms 
constitute about 90% of all dosage forms used in the 
systemic administration of therapeutic agents (Jivraj 
et al., 2000). The widespread use of tablets has been 
achieved as a result of their convenience, stability, 
ease of manufacture and also the diversity of tablet 
types. Tableting components known as excipients 
contribute significantly to the successful formulation 
of robust tablets by modulating its processability, 
stability and bioavailability (Mshelia et al., 2015; 
Nachaegari and Bansal 2004). Hence, they are 
regarded as functional components of any 
formulation (Camargo, 2011). There has been 
increasing preference for direct compression (DC) as 
the method of choice in the formulation of tablets due 
to obvious advantages including shorter processing 
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time involving fewer unit operations and suitable for 
heat or moisture sensitive active pharmaceutical 
ingredients (API) (Odeku et al., 2008; Ogunjimi and 
Alebiowu 2013; Olowosulu et al., 2011). The burden of 
formulating poorly compressible drugs into robust 
tablets by DC is borne largely by the excipients 
utilized in this operation. These excipients constitute 
a greater proportion of any DC formulation relative to 
the active pharmaceutical ingredient (API) and so 
they invariably determine to a large extent the 
functionality of such formulations. This has therefore 
resulted in an increased drive to develop high-
functionality excipients designed for DC 
formulations. Over the years, research in the area of 
excipient development has focussed on the co-
processing of existing excipients to generate a novel 
excipient with improved functionality. Co-processing 
of excipients is a particle engineering process that 
involves the combination of two or more excipients at 
sub-particle level designed to physically modify their 
properties in a manner that cannot be achieved 
through simple physical mixing (Nachaegari and 
Bansal 2004; Saha and Shahiwala 2009). The outcome 
of this intervention has led to the development of a 
single-bodied composite excipient with improved 
functionalities like compressibility, flowability, 
dilution potential etc. (Nachaegari and Bansal 2004; 
Rojas et al., 2012). A combination of a plastic and 
brittle deforming material produces a co-processed 
excipient with desirable attributes for tableting (Wang 
et al., 2015). Many co-processing methods have been 
employed, including spray drying (Chauhan et al.,  
2016; Rojas and Kumar, 2011; Sharma et al., 2015), co-
drying (Mshelia et al., 2015; Olowosulu et al., 2011) 
wet massing, spheronisation, melt extrusion (Goyanes 
et al., 2011), co-precipitation (Kittipongpatana and 
Kittipongpatana 2011), co-grinding (Adeoye and 
Alebiowu, 2014a; Katsuno et al., 2013), wet-, dry– and 
spray-granulation (Daraghmeh et al., 2010) and co-
processing by crystal coating (Vanhoorne et al., 2014) 
among which spray drying is the most widely used 
and successful strategy (Rojas et al., 2012).  
Not much attention has been given to the co-
processing of starches compared to lactose and 
celluloses. Due to its versatility, starch has found 
application as a diluent, disintegrant and binder in the 
formulation of tablets by wet granulation (Odeku, 
2013; Odeku et al., 2008). It is readily available in 
industrial quantities and can be obtained from diverse 
sources. Hence, it will be economically viable to 
embark on a project involving starch as the major 
component. However, starch in its native form is not 
suitable for direct compression due to limitations in 
flowability and compressibility (Adeoye and 
Alebiowu 2014b; Odeku et al., 2008; Olowosulu et al., 
2011). Co-processing of starch with other excipients is 
currently being considered as a measure to improve 
the functionality of starch for direct compression. 
Maize starch (90%) was co-processed with acacia gum 
(ACA, 7.5%) and colloidal silicon dioxide (CSD, 2.5%) 
to improve its compressibility and flowability 
properties respectively. Acacia gum acts as a binder in 
tablet formulation and an emulsifying agent in the 
formation of stable emulsions (Olowosulu et al., 2011). 
The presence of ACA in the maize starch matrix will 
enhance the compressibility of maize starch by 
creating a larger bonding area that will invariably lead 
to increased bonding strength. The role of CSD in the 
co-processed mixture is to promote flowability of 
maize starch by reason of its action as a glidant. It is 
also known to enhance compressibility when 
deposited on the surface of co-processed particles 
providing rough surfaces that facilitates particulate 
bonding by mechanical interlocking (Kittipongpatana 
and Kittipongpatana 2011). Rapid disintegration of 
tablets has been associated with co-processed 
excipients containing CSD due to its ability to create a 
porous network that drives water uptake into the 
tablet resulting in a rapid burst of the tablet in an 
aqueous medium during disintegration (Rojas and 
Kumar 2011). The target of this study therefore was to 
generate a co-processed excipient with 
multifunctional capacity designed for DC using the 
methods of co-dispersion, co-fusion and co-
granulation. The effect of these co-processing 
methods on the powder, compaction and tableting 
properties of the co-processed excipients developed 
were assessed. 
MATERIALS AND METHODS 
Materials 
Materials used include Maize starch (Burgoyne 
Burbidge & Co. India, Mumbai), Magnesium stearate 
(BDH Chemicals Ltd Poole, England), Colloidal 
silicon dioxide (Evonik Industries, Germany), Acacia 
gum (Kerry Ingredients and Flavours Ltd, Ireland), 
Paracetamol powder (BDH Chemicals Ltd Poole, 
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England), Potassium dihydrogen phosphate 
(Guandong Chemical Reagent, China), Sodium 
hydroxide pellets (Qualikems Laboratory Reagent, 
India), Liquid xylene (BDH Chemicals Ltd Poole, 
England), Distilled water (Department of Biological 
Sciences, Ahmadu Bello University, Zaria, Nigeria). 
All other materials used were of analytical grade. 
Preparation of co-processed excipient by co-
dispersion (SAS-CD) 
The co-processed excipient composed of maize starch 
(MS), acacia gum (ACA) and colloidal silicon dioxide 
(CSD) was prepared by co-dispersion technique. A 
suspension of MS (40% w/w) was prepared in distilled 
water and appropriate quantities of ACA gum in 
solution and CSD were added to the suspension in 
that sequence. The entire mixture was stirred for 5 
mins and spread to dry in a tray for 24 h. The partially 
dried mass obtained was passed through a 0.8 mm 
sieve and drying completed in the hot-air oven at 40 
°C for 2 h. The powder obtained was stored in an air-
tight container prior to further use. 
Preparation of co-processed excipient by co-fusion 
(SAS-CF) 
The entire process was repeated as above except that 
the dispersed mixture obtained was transferred to a 
water bath set at 54˚C (±2˚C) for 15 mins with periodic 
stirring. It was allowed to cool to room temperature, 
stirred and the mixture spread on a tray exposed to 
dry partially for 24 h. The partly dried mass obtained 
was passed through a 0.8 mm sieve and the co-
processed particles formed were dried finally in hot 
air oven at 40 ˚C for 2h. 
Preparation of co-processed excipient by co-
granulation (SAS-CG) 
A powder blend of MS and CSD was prepared in a 
mortar using the doubling up technique. It was then 
granulated with a binder solution of ACA gum, force-
screened through a 1 mm sieve and the granules 
formed were allowed to dry partially in the hot-air 
oven at 40 ˚C for 20 min. The granules were then 
passed through a 0.8 mm sieve and drying completed 
in the oven at 40 ˚C for 2 h. The granules were kept in 
an air-tight container for further studies. 
Optical microscopy 
Optical images of SAS-CD, SAS-CF and SAS-CG were 
taken at × 400 magnification using the Amscope 
digital camera for microscope (MT 500, Made in 
Japan). The mean median particle (d50) size of each 
material was also determined by microscopy. 
Angle of repose 
The angle of repose for each sample of co-processed 
excipient was measured using the fixed funnel 
method. The powder was allowed to flow freely from 
a height of 8 cm under the influence of gravity and a 
conical heap of powder was formed at the base. The 
dimensions of height and radius were measured and 
used to compute the angle of repose using the formula 
below. The mean of three determinations was 
reported for each sample. 
𝑇𝑎𝑛 𝜃 =
ℎ
𝑟
     (1) 
Determination of bulk and tapped densities 
Bulk and tapped densities were determined for each 
sample of the co-processed excipient using 30 g of 
powder. The powder was poured into a measuring 
cylinder at an angle of 45° and the volume occupied 
was recorded as bulk volume (VB).  The cylinder was 
tapped to constant volume and recorded as tapped 
volume (VT). A mean of three observations was 
recorded for each sample.  The bulk and tapped 
densities calculated using the equations given below 
were also used to determine Carr’s index and 
Hausner’s ratio. 
𝐵𝐷 =
𝑤𝑒𝑖𝑔ℎ𝑡
𝑏𝑢𝑙𝑘 𝑣𝑜𝑙𝑢𝑚𝑒(𝑉𝐵)
     (2) 
𝑇𝐷 =
𝑤𝑒𝑖𝑔ℎ𝑡
𝑡𝑎𝑝𝑝𝑒𝑑 𝑣𝑜𝑙𝑢𝑚𝑒(𝑉𝑇)
    (3) 
𝐶𝐼 =
𝑇𝐷−𝐵𝐷
𝑇𝐷
 𝑋 100     (4) 
𝐻𝑅 =
𝑇𝐷
𝐵𝐷
      (5) 
Particle density  
Particle densities of the three samples of co-processed 
excipient were determined as described by Alebiowu 
and Femi-Oyewo (1998). An empty density bottle was 
weighed, filled with xylene and reweighed. A little 
quantity of xylene was poured out and 1g of each 
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sample was introduced into the density bottle 
containing xylene. The bottle was then filled with 
xylene and weighed again. The particle density was 
calculated using the formula given below: 
𝑃𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 =
(𝑊2 𝑋 𝑊3)
50(𝑊3−𝑊4+𝑊2+𝑊)
  (6) 
Where; W is weight of empty density bottle, W2 
weight of xylene (w1−w), W1 is weight of the bottle 
filled with xylene, W3 is weight of the sample, and W4 
is weight of the bottle filled with xylene and sample. 
Moisture content determination 
The amount of moisture contained in each sample was 
determined by drying 1 g of the sample at 105 °C to 
constant weight. Moisture content (%MC) was 
calculated using the formula below; 
% 𝑀𝐶 =
𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑤𝑒𝑖𝑔ℎ𝑡−𝑓𝑖𝑛𝑎𝑙 𝑤𝑒𝑖𝑔ℎ𝑡
𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑤𝑒𝑖𝑔ℎ𝑡
 𝑋 100  (7) 
Lubricant sensitivity ratio (LSR) 
The sensitivity of each sample of co-processed 
excipient to lubricant was assessed using the LSR test 
(Camargo, 2011). The sample powder (4.95 g) was 
blended with magnesium stearate (0.05 g) for 5 min. 
Tablets (500 mg) were produced by direct 
compression on an eccentric Tablet Press (Type EKO, 
Korsch, Germany) fitted with 12 mm flat-faced 
punches and compressed at 216 MPa. Tensile strength 
was determined after 24 h as described by Fell and 
Newton (Gamlen et al., 2015). The entire process was 
repeated for tablets prepared without lubricant. 
Lubricant sensitivity ratio was calculated by fitting 
the data obtained into Eq.9. 
𝐿𝑆𝑅 =  
𝑇0−𝑇𝑙
𝑇0
 𝑋 100      (8) 
Where; T0 is the tensile strength of tablet without lubricant, 
and Tl is the tensile strength of tablet with lubricant 
𝑇𝑆 =
2𝑋𝐶𝑠𝑋10
𝜋𝑑𝑡
     (9) 
Where; CS is the crushing strength, 𝜋 is 3.142, d is the 
diameter of die cavity (12 mm), and t is the thickness 
of the tablet. 
Dilution potential studies 
Each batch of the co-processed excipient was mixed 
with paracetamol in the following ratios; 20:80, 40:60, 
50:50, 60:40, 80:20, and compressed into tablets (500 
mg) at a compression force of 10 KN using a 12 mm 
flat-faced punch and die set. The tablets were 
analysed for their tensile strength calculated using 
equation 10. A plot of mass fraction of the excipient 
against the tensile strength was generated for each 
material. 
Fourier Transform Infrared Spectroscopy (FT-IR) 
studies 
FT-IR scans were collected for each sample of co-
processed excipient from 650 – 4000 cm-1 using 
Agilent Cary 630 FTIR Spectrometer (USA). For each 
spectrum, 16 scans were recorded at a resolution of 4 
cm−1. Analysis of the spectra was done using the 
MicroLab software. 
Compaction studies 
Compaction experiments were conducted on the three 
samples of the co-processed excipient using a 
computer-controlled portable bench-top tablet press 
(Model GTP-1, Gamlen Tableting Ltd, Nottingham, 
UK). 70 mg powder was filled manually into the die 
cavity measuring 5 mm and compressed at a speed of 
60 mm/min at loads ranging from 100 – 500 kg (49.66 
– 224.77 MPa). Tablets were ejected in the same 
direction as compression while the tensile strength 
and ejection stress were measured for each tablet with 
the tablet press. The tablet detachment (take-off) force 
was recorded using a manually operated 500 N 
McMesin CFG+ force transducer. Data was also 
collected on the weight and thickness of tablets 
formed and used to compute the volume, apparent 
density and relative density (D) of the tablets from the 
equations below:    
𝑉𝑜𝑙𝑢𝑚𝑒 =  𝜋𝑟2ℎ     (10) 
𝐴𝑝𝑝𝑎𝑟𝑒𝑛𝑡 𝐷𝑒𝑛𝑠𝑖𝑡𝑦 =
𝑤
𝜋𝑟2ℎ
    (11) 
𝐷 =
𝐴𝑝𝑝𝑎𝑟𝑒𝑛𝑡 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
𝑃𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
    (12) 
Where r, h and w represents radius, thickness and 
weight of tablet respectively. 
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The data obtained from compaction studies was used 
to generate Heckel (Heckel, 1961) and Walker 
(Walker, 1923) plots from the equations below; 
𝐼𝑛 (
1
𝜀
) = 𝑃𝐾 + 𝐴     (13) 
Where Ԑ is the porosity of the compact, P is the applied 
pressure, K is the slope of the linear portion of the plot 
and A is the intercept on the y axis. 
𝑉′ = −𝑤′ log 𝑃 + 𝑉𝑠𝑝′     (14) 
Where V′ is the specific volume of a compact and w′ 
is the Walker coefficient expressing the volume 
reduction corresponding to one decade change in 
pressure P and Vsp′ is the specific volume at pressure 
1. W′ is a measurement of the powder’s 
compressibility. 
Tableting 
Tablets (500 mg) containing paracetamol were 
prepared by direct compression on an eccentric Tablet 
Press (Type EKO, Korsch, Germany) equipped with a 
12 mm flat-faced punches compressed at 216 MPa. 
Prior to tableting, the powder mix of drug and 
excipient was lubricated with 1% magnesium stearate.  
Tablets were stored for 24 h to allow for elastic 
recovery prior to evaluation of the tablet properties. 
The three batches of tablets produced were evaluated 
for weight variation, thickness, tensile strength, 
friability, disintegration and dissolution. The formula 
for preparing tablets is given in Table 1 below. 
Table 1. Formula for paracetamol tablets prepared using SAS-
CD, SAS-CF and SAS-CG 
Ingredients One tablet (mg) 
Paracetamol (50%) 250 
*DC Excipient (49%) 245 
Mag. Stearate (1%) 5 
Total 500 
* DC Excipient: SAS-CD, SAS-CF or SAS-CG 
Dissolution studies 
The amount of drug released by paracetamol tablets 
was measured according to USP (2011) using rotating 
basket method in 900 mL of pH 5.8 buffer solution 
maintained at 37 ± 0.5˚C using a dissolution tester. 
5 mL samples were withdrawn at intervals of 5, 10, 20, 
30, 45, and 60 mins respectively. The dissolution 
medium was replaced with equal volume of the buffer 
solution after each withdrawal. Each sample 
withdrawn was filtered and 1 mL of the filtrate taken 
and diluted to 10 mL using the buffer solution. The 
absorbance values of the final solutions were taken at 
244 nm using the UV spectrophotometer (Shimadzu 
Corporation, USA). This was done for the three 
batches of tablets. The concentration of paracetamol in 
each sample was then calculated using the equation 
extrapolated from the Beer-Lambert’s plot of 
paracetamol. 
RESULTS AND DISCUSSION 
Particle and bulk properties 
The goal of co-processing is to improve the 
functionality of the interacting excipients. There is a 
correlation between the powder properties of the co-
processed excipient and its functionality in tableting. 
The performance of an excipient in terms of flow, 
compression and dilution potential in DC has been 
credited to its particle size, shape, surface properties 
and deformation behaviour. Changes occurring at 
particle level have been shown to significantly affect 
the functionality of the excipient (Sun et al., 2009). It is 
imperative therefore to characterize the powder 
properties of an excipient considering its impact on 
functionality.  The particle and bulk characteristics of 
the co-processed excipient labelled SAS-CD, SAS-CF 
and SAS-CG are presented in Table 2. The mean 
median particle size (d50) ranged from 120 – 290 µm 
with co-processed particles of SAS-CG having the 
largest size. This has been attributed to the method of 
processing which involves the agglomeration of 
primary particles facilitated by the formation of liquid 
bridges during granulation. Co-processed particles of 
SAS-CF were slightly bigger than those of SAS-CD 
owing to the fusion of particles that may have 
occurred in the course of heating the mixture at 
pregelatinization temperature. Hence, the method of 
co-processing influenced the outcome of the particle 
size of the generated co-processed excipients. Co-
processing by spray-drying has yielded a significant 
increase in particle size compared to other methods 
(Chauhan et al., 2016; Rojas and Kumar 2011; Sharma 
et al., 2015; Vanhoorne et al., 2014). Engineering the 
particle size during co-processing plays a key role in 
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defining the functionality of the co-processed 
excipient. Particle size enlargement confers 
improvement in flowability particularly for materials 
designed for direct compression. 
Another critical factor to be considered in the 
formulation of tablets by direct compression is the 
flowability of the powder mix. Most direct 
compression formulations are composed of the 
excipient in greater proportion compared to the API 
hence the flowability of the powder mix may be 
directly related to the flow characteristics of the direct 
compression (DC) excipient. The angle of repose 
values presented in Table 2 ranks the three materials 
in the following order, SAS-CF < SAS-CD < SAS-CG 
with SAS-CF having the least angle of repose (28.9 °). 
As a general rule, angle of repose values not exceeding 
30° is acceptable for good flow properties. This 
suggests that all three materials possessed marginal 
flow properties.
Table 2. Particle and bulk characteristics of SAS-CD, SAS-CF and SAS-CG. Values in parentheses represent standard deviation (n=3) 
Parameters SAS-CD SAS-CF SAS-CG 
Median particle size (d50) 120 (10) 160 (13.2) 290 (20) 
Angle of repose (°) 31.2 (0.21) 28.9 (0.57) 34.7 (0.21) 
Bulk density (g/mL) 0.53 (0.01) 0.59 (0.0) 0.33 (0.0) 
Tapped density (g/mL) 0.6 (0.0) 0.68 (0.0) 0.38 (0.0) 
Hausner’s ratio 1.14 (0.01) 1.13 (0.0) 1.11 (0.05) 
Carr’s index (%) 12.5 (1.13) 12.5 (0.99) 12 (0.0) 
Particle density (g/mL) 1.44 (0.02) 1.46 (0.01) 1.46 (0.01) 
Moisture content (%) 2.3 (0.2) 2.2 (0.4) 2.3 (0.3) 
Lubricant sensitivity ratio 
(%) 
63.3 (3.04) 76.8 (3.27) -50.7 (5.17) 
Optical images of the three materials displayed as Fig. 
1 shows that the particles appear spherical in shape. 
Spherical shaped particles favour the rapid flow of 
powders and granules during tableting by ensuring 
minimal contact which lowers interparticulate 
friction. The bulk and tapped density values of SAS-
CG were significantly lower than the other two 
materials owing to its larger particle size which 
prevents closer packing during densification resulting 
in more pore spaces (porosity) and more volume 
occupied by the powder. Lower bulk density has been 
associated with better dilution potential due to its 
ability to accommodate more of the poorly 
compressible drug in its pore spaces (Thoorens et al., 
2014). Other parameters for assessing the flowability 
of a material such as Carr’s index and Hausner’s ratio 
were consistent with good flow properties for all three 
materials. Particle density did not differ significantly 
for the three materials as they were all generated from 
the same composition of excipients. Moisture content 
ranged from 2.2 – 2.3% and did not differ significantly 
across the three materials. Moisture exerts a 
plasticizing effect and promotes flowability when 
present in optimal level in tableting formulations 
(Thapa et al., 2017). It is therefore necessary to control 
moisture content to optimize tablet quality. 
The sensitivity of a material to lubricant is a property 
that is critical to the success of any formulation (Paul 
and Sun, 2017; Sun, 2011). Lubricants are normally 
added as extragranular excipients to prevent sticking 
of the formulation to the punch and die surfaces and 
facilitate smooth ejection of the tablet after 
compression. However, lubricants are known to exert 
negative effect on tablets with respect to its crushing 
strength and disintegration time (Patel et al., 2006; 
Paul et al., 2016; Sun, 2011). The coating of particles 
with lubricants limits bond formation leading to 
lower crushing strength while the hydrophobic 
nature of lubricants like magnesium stearate does not
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Fig. 1. Photomicrographs of (A) SAS-CD, (B) SAS-CF and (C) SAS-CG taken at magnification (x 400) 
permit the influx of water during disintegration 
thereby extending disintegration time and by 
extension dissolution and bioavailability of the drug. 
The lubricant sensitivity ratio (LSR) determined for all 
three materials shows that SAS-CF was most sensitive 
to lubricant action while SAS-CG was least sensitive 
because it returned a negative value indicating that 
tensile strength improved in the presence of 
lubricants. The deformation of SAS-CG by brittle 
fracture during compression may have led to the 
formation of new surfaces which were not coated by 
lubricants thereby producing compacts with greater 
tensile strength. 
It was necessary to determine the dilution potential of 
the materials because they were designed for use as 
direct compression excipients. Dilution potential is a 
measure of the material’s ability to compress large 
amounts of a poorly compressible drug and still retain 
its compressibility (Adeoye and Alebiowu 2014; 
Camargo, 2011; Chauhan et al., 2016). The dilution 
potential of a material gives us an insight into the 
tablet formula and how much of the poorly 
compressible drug can be loaded to give robust tablets 
with the DC excipient. The dilution potential plot 
generated for all three materials is presented as Figure 
2. Tensile strength of compacts decreased with 
increasing proportion of the poorly compressible 
drug (paracetamol). The tensile strength of compacts 
produced with SAS-CG was highest across the range 
of proportions used for all three materials. To obtain 
compacts of 1 MPa, about 200 mg of SAS-CG was 
required to produce 500 mg tablets containing 300 mg 
of paracetamol. However, the duo of SAS-CD and 
SAS-CF could not produce compacts of 1 MPa even 
when used in higher proportions exceeding the 
amount of SAS-CG that generated the 1 MPa 
compacts.  This indicates that SAS-CG has a better 
dilution potential compared to the other two and will 
therefore accommodate more drug in its formulation 
resulting in normal sized tablets. The process of 
obtaining SAS-CG by co-granulation technique may 
have improved its dilution capacity as the acacia gum 
forms a coat on the surface of the co-processed 
particles providing a better binding surface to adhere 
the drug (Sun, 2017).  
 
Fig. 2. Dilution potential plot showing the relationship between 
the proportions of excipient (mass fraction) used in the 
formulation and the tensile strength of tablets produced (n=5). 
FT-IR studies 
The FT-IR spectra generated for SAS-CD, SAS-CF and 
SAS-CG are displayed as Figure 3. FT-IR was carried 
out to ascertain if there will be any changes occurring 
in the chemical structure of the co-processed excipient 
as a result of the method employed. The spectra for all 
three materials were found to be similar with major 
peaks/bands occurring with the same intensity and 
frequency. Characteristic absorption bands were 
observed at 3272, 2929, 1636, 1420, 1148, 1077, 991 and 
928 cm-1 positions corresponding to O-H stretch, C-H 
stretch, C=O stretch, O-Si-O, C-N stretch, O-H bend 
and =C-H bend respectively for all three materials. 
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Fig. 3. FT-IR spectra of (A) SAS-CD, (B) SAS-CF, and (C) SAS-CG
(C)
(B)
(A)
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This implies therefore that the methods of co-
processing employed did not produce any chemical 
change in the excipients developed principally 
because they are entirely physical processes. The 
characteristic IR bands occurring in the individual 
excipients were maintained in the co-processed 
excipient. 
Compaction profile 
The compaction profiles of the three co-processed 
excipients were evaluated using the Heckel (Heckel, 
1961) and Walker (Walker, 1923) models. Heckel and 
Walker are empirically based models and differ in the 
parameter by which they describe deformation 
behaviour (Egart et al., 2014). The Heckel plot which 
illustrates a porosity-pressure relationship is 
presented as Figure 4A.  
Porosity of the compacts decreased as the compaction 
pressure increased for all the materials. The material’s 
ability to deform during compaction was quantified 
using the yield pressure calculated as the reciprocal of 
the slope of the linear portion of the plot. The yield 
pressure (PY) alongside other Heckel parameters is 
given in Table 3. This is the pressure that characterizes 
the onset of deformation and lower values indicate a 
higher degree of plasticity in the material. Comparing 
the Heckel profile of the three materials, SAS-CG had 
the least PY (160.9 MPa) suggesting a faster onset of 
deformation during compaction. Plastic deformation 
facilitates the formation of tablets because particles 
are brought in close proximity to each other as a result 
of the irreversible deformation which increases the 
contact area available for bonding. The total degree of 
densification (DA) attributed to particle 
rearrangement at low pressures was slightly higher 
with SAS-CD and SAS-CF in comparison to SAS-CG. 
This can be attributed to the larger surface area due to 
smaller particle size of both materials which occupied 
less volume during die-filling and particle 
rearrangement at low pressure resulting in a greater 
degree of densification. The extent of densification 
occurring as a result of particle fragmentation (DB) did 
not differ significantly across the three materials. 
Table 3. Heckel and Walker parameters for SAS-CD, SAS-CF 
and SAS-CG 
 Heckel Walker 
Material PY (MPa) DA D0 DB W' 
SAS-CD 234.4 0.62 0.37 0.25 26.7 
SAS-CF 211.3 0.60 0.4 0.20 28.7 
SAS-CG 160.9 0.47 0.23 0.24 45.5 
The Walker plot shown in Figure 4B considers 
changes in the specific volume of the compact as a 
function of compaction pressure. The plot shows a 
trend of decreasing specific volume with increase in 
compaction pressure for all three materials. The 
Walker coefficient (W') which measures the 
compressibility of the material is also given in Table 3. 
Higher values of W' implies better compressibility, 
hence, SAS-CG had a better compression profile 
compared to the other two materials. This is consistent 
with the observations recorded with the Heckel 
analysis. The Walker model may be considered as a 
better tool in classifying the deformation behaviour of 
a material because of its highly discriminative power 
 
Fig. 4. Compaction plots of SAS-CD, SAS-CF and SAS-CG. (A) Heckel Plot and (B) Walker Plot (n=3) 
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compared to Heckel analysis. Some criticisms have 
been recorded against the Heckel model with regards 
to its accuracy and robustness (Sonnergaard, 1999). 
Contrastingly, the Walker model is more robust and 
less sensitive to the approach used (Ilić et al., 2013). 
Notwithstanding, Heckel and Walker analysis have 
been able to predict and determine optimum tableting 
properties usually obtained with plastic and brittle 
fracture deforming materials (Alakayleh et al., 2016). 
Compressibility and compactibility are two vital 
indicators that contribute to the tabletability of a 
material (Egart et al., 2014). The compressibility-
tabletability-compressibility (CTC) profile of all three 
materials is illustrated in Figure 5A-C. 
Compressibility is the measure of the ability of a 
material to contract in volume under the effect of 
compaction pressure and it is represented as a tablet 
porosity-pressure relationship (Ghori and Conway 
2016; Khomane et al., 2013; Patel et al., 2006; 
Upadhyay et al., 2013) as seen in Fig. 5A. The trend 
observed shows that the porosity of the compact 
decreases with increasing compaction pressure for all 
the materials. This occurred as a result of extensive 
packing occurring at higher compaction pressures 
leading to lower porosities (Alakayleh et al., 2016). 
There was a slight difference in the extent of porosity 
reduction obtained with SAS-CG compared with the 
other two materials. At lower pressures, the porosities 
of compacts obtained with SAS-CD and SAS-CF were 
lower than that of SAS-CG. This has been attributed 
to the larger particle size of SAS-CG which requires 
more work of compression to rearrange the particles, 
deform and finally to fragment them (Alakayleh et al., 
2016). However, at higher pressures where particle 
fragmentation must have taken place to fill up the 
interparticulate pores during rearrangement coupled 
with plastic deformation, the extent of porosity 
reduction observed with SAS-CG seem to surpass the 
other two yielding compacts with lower porosity. The 
reduction in porosity as a measure of compressibility 
suggests that more surface area of particles will be 
available for bonding (Osei-Yeboah and Sun 2015; Sun 
2011).  
Fig. 5. CTC plots for SAS-CD, SAS-CF and SAS-CG. (A) Compressibility Plot (B) Compactability Plot and (C) Tabletability Plot (n=3) 
Compactibility is a measure of the ability of a material 
to form compacts of sufficient tensile strength under 
the effect of densification (Ghori Conway 2016; Joiris 
et al., 1998; Upadhyay et al., 2013; Yadav et al., 2017). 
It is illustrated as a plot of tensile strength against 
porosity in Fig. 5B. For all three materials, tensile 
strength of compacts increased with a decrease in 
porosity. The particles were brought in close 
proximity to each other at low porosity to facilitate 
bonding which results in an increase in tensile 
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strength (Ogunjimi and Alebiowu 2014). The tensile 
strength of a tablet is an outcome of the bonding area 
between adjacent particles and bonding strength 
(strength of the interaction over a unit area) (Osei-
Yeboah et al., 2016). The plot shows that compacts of 
higher tensile strength were obtained with SAS-CG at 
the same level of porosity when compared to SAS-CD 
and SAS-CF. This is consistent with Heckel analysis 
that showed a lower yield pressure because of 
plasticity. A greater degree of plasticity brings 
particles in close proximity to each other allowing 
stronger bond formation at higher compaction 
pressures. More contact points were therefore 
generated in compacts involving SAS-CG. Certain 
extrinsic powder characteristics such as particle size, 
size distribution, surface area, bulk density and 
porosity may have impacted on the compressibility 
and compactibility of these materials as seen in other 
studies (Egart et al., 2014; Khomane et al., 2013).  
Tabletability is the capacity of a powdered material to 
be transformed into a tablet of specified strength 
under the effect of compaction pressure (Ghori and 
Conway, 2016; Joiris et al., 1998; Upadhyay et al., 2013; 
Yadav et al., 2017). It is represented by a plot of tensile 
strength against compaction pressure (Fig. 5C). The 
plot shows that tensile strength of compacts produced 
increased across the range of compaction pressures 
utilized for all three materials. This was expected as 
increasing the compaction pressure led to more 
energy being transmitted to the powder bed during 
the compaction process and allowing more 
interparticulate bond formation (Xu et al., 2016). The 
tensile strength of compacts obtained with SAS-CD 
and SAS-CF were lower than that of SAS-CG at the 
same compaction pressure indicating that a greater 
degree of tabletability was attained with SAS-CG due 
to the combined effect of bonding area 
(compressibility) and bonding strength 
(compactibility). It also implies that a greater degree 
of elastic recovery may have occurred with SAS-CD 
and SAS-CF compacts during decompression that 
may have lowered the tensile strength relative to SAS-
CG compacts. The tabletability of a material is crucial 
to the formation of robust tablets devoid of tableting 
defects like capping and lamination. Hence, only 
excipients that will enhance the tabletability of a 
formulation should be selected. 
To evaluate the lubrication potential of the three 
materials, the parameters of ejection shear stress and 
detachment force were obtained during powder 
compaction. Figure 6A and B represents the ejection 
shear stress and detachment force plots respectively. 
Ejection shear stress is the stress generated during the 
tablet ejection process and it is represented by a plot 
of ejection shear stress against compaction pressure 
(Gamlen, 2017; Pitt et al., 2015). The plot shows an 
increase in ejection shear stress as the compaction 
pressure increases for all three materials. 
Fig. 6. (A) Ejection and (B) Detachment Plots for SAS-CD, SAS-CD and SAS-CG (n=3) 
Similarly, the detachment force plot shows an increase 
in detachment force as compaction pressure increases 
for all three materials. This parameter describes the 
force required to detach a tablet from the punch face 
once it is ejected from the die. Of the three materials, 
SAS-CG gave the highest ejection shear stress and 
detachment force across the range of compaction 
pressures employed indicating that it had limited self-
lubricating property. This could be attributed to the 
high tensile strength of tablets produced by SAS-CG 
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which increases the stress and force for ejection and 
detachment respectively during tableting. SAS-CD 
and SAS-CF had lower ejection shear stress and 
detachment force suggesting a greater degree of self-
lubricating potential.  Ejection shear stress > 5 MPa 
has been associated with manufacturing problems 
like capping and lamination (Gamlen, 2017; Pitt et al., 
2015). To avoid the occurrence of tableting defects 
with the use of these materials in tableting, it will be 
necessary to properly lubricate formulations 
containing these materials. 
Tablet properties 
The physical properties of paracetamol tablets 
produced by direct compression with the developed 
co-processed excipients are given in Table 4. Mean 
tablet weight ranged between 499.2 – 511.3 mg. Based 
on the target tablet weight of 500 mg, the % limit 
allowed for variation is 5%. Hence, all the batches 
passed the weight variation test according to the USP 
requirements. Uniformity in weight of tablets has 
been attributed to the uniform flow of the formulation 
mix during the filling of the die leading to 
compression. This is a critical stage as poor flow will 
lead to a wide variation in tablet weight that may 
adversely affect content uniformity of tablets. The 
thickness values obtained for each batch of tablets 
correlated well with the mean tablet weight as higher 
thickness values corresponded to higher mean tablet 
weight. Tensile strength of tablets did not differ 
significantly across the batches even though the CTC 
profile revealed slight differences among the three 
materials. Notwithstanding, the friability of tablets 
showed some degree of variation among the three 
materials. The widely acceptable limit for friability is 
1% and only tablets of SAS-CG satisfied the 
requirement. This may be attributed to the 
predominant plastic deformation profile of SAS-CG 
that facilitated the formation of stronger bonds during 
compression resulting in tablets of sufficient 
mechanical strength. The higher yield pressure (PY) 
obtained for SAS-CD and SAS-CF during Heckel 
analysis is an indication that a greater degree of 
deformation occurred by fragmentation (brittle 
fracture). Hence, it is more likely that weaker tablets 
will be formed by these materials as reflected in the 
friability.  Evaluation of disintegration time shows 
that all the batches of tablets disintegrated within 1 
min which is typical for co-processed excipients 
containing colloidal silicon dioxide (El-Barghouthi et 
al., 2008; Nagpal et al., 2012; Rojas and Kumar, 2011). 
A more rapid disintegration was observed in SAS-CG 
tablets. This may have occurred as a result of the low 
bulk density of SAS-CG characterized by the presence 
of intergranular pore spaces creating more room for 
water uptake. There is also the likelihood of a 
preferential distribution of colloidal silicon dioxide on 
the surface of the co-processed particles of SAS-CG 
generated by co-granulation that creates a network of 
channels on the surface of tablets facilitating the rapid 
uptake of water during disintegration. The drug-
release profiles of SAS-CD, SAS-CF and SAS-CG is 
presented as Fig. 7. Maximum drug release did not 
exceed 45% after 60 mins suggesting that more time 
will be required to attain 100% released. Even though 
disintegration of tablets was rapid, dissolution did not 
follow the same pattern as expected. There is a remote 
possibility that the drug, paracetamol was tightly 
bound by the excipient and so a longer time will be 
required to release the drug into solution. It goes to 
say that rapid disintegration does not always translate 
into rapid dissolution as tablets only disintegrate into
Table 4. Physical properties of tablets produced with the three co-processed excipients. Values in parentheses represent ±SD, (n=6) 
Properties SAS-CD SAS-CF SAS-CG 
Weight uniformity (g) 511.3 (9.2) 502.8 (14.3) 499.2 (10.1) 
Thickness (mm) 4.32 (0.1) 4.27 (0.04) 4.11 (0.15) 
Crushing strength (N) 76 (11.4) 85 (8.7) 85 (7.1) 
Tensile strength (MN/m2) 0.93 (0.14) 1.06 (0.11) 1.1 (0.09) 
Friability (%) 1.54 (0.03) 1.91 (0.06) 0.81 (0.04) 
Disintegration time (min) 0.85 (0.08) 0.62 (0.1) 0.37 (0.04) 
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fragments containing the drug which has to be 
released into solution. This agrees with the findings of 
Odeku (2005) where 100% release of paracetamol was 
achieved in 120 mins. 
 
Fig. 7. Dissolution plot showing the in vitro drug release profiles 
of SAS-CD, SAS-CF and SAS-CG 
CONCLUSIONS 
A comparative study was carried out to evaluate the 
effect of different co-processing methods on the 
powder and tableting properties of a co-processed 
excipient consisting of MS (90%), ACA (7.5%) and 
CSD (2.5%). The methods of co-processing evaluated 
generated SAS-CD (co-dispersion), SAS-CF (co-
fusion) and SAS-CG (co-granulation) as co-processed 
excipients. Characterization of the powder properties 
of the three excipients revealed similarities in the flow 
parameters, particle density and moisture content 
while differences were observed in the particle size, 
dilution potential and LSR which can be attributed to 
the method of co-processing. FT-IR analysis did not 
reveal any chemical change occurring in the material 
as a result of the method of co-processing. 
Compaction and tableting properties of the three 
excipients showed that SAS-CG exhibited a greater 
degree of plastic deformation owing to the lower yield 
pressure obtained in comparison to the other two 
excipients. This facilitated the formation of tablets 
with sufficient mechanical strength, rapid 
disintegration and minimal friability.  
Summarily, the findings reveal that SAS-CG 
produced by co-granulation performed better in 
terms of powder, compaction and tableting properties 
owing to the effect of particle size, bulk density, 
surface properties and deformation behaviour 
modulated by the method of co-processing. This 
study therefore highlights the importance of selecting 
a robust method for co-processing that will deliver the 
desired functionality in tableting. 
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